Eli Lilly Was Hoping for 5 Big Drug Launches This Year. Here's How It Has Done Thus Far.

Eli Lilly Was Hoping for 5 Big Drug Launches This Year. Here's How It Has Done Thus Far.

Source: 
Motley Fool
snippet: 
  • Eli Lilly set some ambitious goals for 2023, highlighting a promising mix of assets in its portfolio.
  • The company has obtained multiple drug approvals this year.
  • It has also upgraded its guidance.